| 期刊簡介 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY LetPub Score 5.2
50 ratings
Rate
Reputation 6.4 Influence 3.8 Speed 7.0 | ||||||||||||||||||||||||
| 期刊簡稱 | J PEDIAT HEMATOL ONC | ||||||||||||||||||||||||
| ISSN | 1077-4114 | ||||||||||||||||||||||||
| E-ISSN | 1536-3678 | ||||||||||||||||||||||||
| h-index | 72 | ||||||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||||||
| 自引率 (2023-2024) | 11.10%自引率趨勢 | ||||||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||||||
| 官方網站 | http://journals.lww.com/jpho-online/pages/default.aspx | ||||||||||||||||||||||||
| 在線稿件提交 | http://www.editorialmanager.com/jpho/default.aspx | ||||||||||||||||||||||||
| 開放訪問 | No | ||||||||||||||||||||||||
| 出版商 | Lippincott Williams and Wilkins Ltd. | ||||||||||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||||||||||
| 出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
| 發行頻率 | 隔月刊行 | ||||||||||||||||||||||||
| 創刊年 | 1995 | ||||||||||||||||||||||||
| 每年文章數 | 153每年文章數趨勢 | ||||||||||||||||||||||||
| 黃金OA百分比 | 6.00% | ||||||||||||||||||||||||
| Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1077-4114%5BISSN%5D | ||||||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2.5 Month(s) | ||||||||||||||||||||||||
| 競爭力 * | 來自作者的數據: About 25% | ||||||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||||||
| *所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY] 的評論 | 撰寫評論 |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:36:10 評論於 We suggest dividing the discussion of research limitations into three parts: (1) identifying research limitations; (2) explaining research limitations in detail; and (3) proposing future research directions or improvements. By discussing research limitations in this order, you can clearly highlight the shortcomings of the study without compromising its quality and validity |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 13:21:09 評論於 It is still necessary for us to clearly specify the limitations of the research in the paper, and explain how these limitations affect the conclusions of the paper. This helps reviewers and other readers understand that we have fully considered the limitations of the study. Discussing the limitations of the research work in the discussion section typically enhances the credibility of the article. Thinking about how to overcome these limitations in future research can have a positive impact |
| 作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 17:00:44 評論於 How to write about the limitations of a discussion? |
| 作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 12:41:09 評論於 Is it necessary to explain the limitations of the article in the discussion? |
| 作者: Baron Jonah 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-07 20:49:23 評論於 Would it affect the review if the author does not fill in the confirmation email? |
| 作者: Baron Jonah 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-07 16:56:33 評論於 Will it affect the review if the author does not fill in the confirmation email? |
| 作者: Baron Jonah 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-07 13:47:45 評論於 Does the author's failure to fill in the confirmation email affect the review process? |
| 作者: Baron Jonah 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-07 11:55:00 評論於 Would it affect the review process if the author does not fill in the confirmation email? |
| 作者: Baron Jonah 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-07 11:50:57 評論於 Will it affect the review if the author does not fill in the confirmation email? |
| 作者: Baron Jonah 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-07 09:40:36 評論於 Will it affect the review if the author's confirmation email is not filled in? |
| 作者: 神古爱梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-01-10 15:11:50 評論於 Thank you |
| 作者: 神古爱梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-12-13 11:16:16 評論於 How much is the review fee? |
| 作者: Benjamin Guy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-02-08 19:58:26 評論於 Lan Er 2020-01-02 00:00:00 posted: A letter can be considered as an article, how many cases have you reported? |
| 作者: 震雷困顿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-01-01 19:31:35 評論於 The letter is considered a dissertation. How many cases did you report? |
| 作者: Benjamin Guy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-11-14 12:41:49 評論於 Review speed: 6.0 | Submission success rate: 75.0 Experience sharing: Submitted a case report as a letter. The first review took 5 months with minor revisions requested. After completing the revisions and resubmitting, it was accepted 3 weeks later |
| 作者: Oliver Jerry 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-24 12:27:09 評論於 The wait is too long |
| 作者: 灵犀秋阳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-21 23:16:00 評論於 The feedback on revision suggests that only one cell strain was used, which took three months, and an experiment using two additional cell strains was conducted as requested. However, after two months of review, it was rejected. The reason given was that the submission rate was only 25%. How could you reject me at the first review?! |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 10:28:07 評論於 So-so, as long as I can graduate, my senior brother published an article last year, it can also be considered a successful graduation, then everything will be fine |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-07-03 17:23:02 評論於 Review Speed: 3.0 | Submission Acceptance Rate: 25.0 Experience Sharing: This journal has a relatively slow review process. It took about three months for the first review to provide comments and major revisions. It also took several weeks after the revisions to receive a rejection notice. Consulting with senior colleagues who have previously submitted to the journal, they also experienced a long review period |
| 作者: Isabel Raman 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-10-26 13:10:51 評論於 Review speed: 2.0 | Submission hit rate: 25.0 Experience sharing: The laboratory has submitted five papers in the past five years, but only one has been accepted. The papers that were not accepted were all submitted to journals with an impact factor of 2.58 or similar, and they were all accepted. Personally, I feel that JPHO values the direction of submission very much. If the content of the article meets its requirements, it is more likely to be accepted. Now I have just submitted one article and hope to receive good news soon |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 22:48:23 評論於 Research focus: Pediatrics |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2010-09-16 22:02:29 評論於 Research Focus: Pediatrics |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us